Position in PTCT
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$3,044,192
+$1,980,547 QoQ
Shares Held
37,320
+139.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#119
of 380 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $24,564,619 across 12 Biotechnology names. PTCT ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
22,078 | $5,320,135 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,478 | $3,072,967 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
This page
|
37,320 | $3,044,192 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
42,252 | $2,400,336 | |
| 5 | INCY |
Incyte Corp
|
20,165 | $2,285,904 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
55,769 | $2,181,683 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
24,156 | $2,100,363 | |
| 8 | ANAB |
Anaptysbio, Inc
|
22,557 | $1,522,597 |
All Filings in PTCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,044,192 | 37,320 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,063,645 | 15,612 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,018,181 | 26,569 | Shares | Sole | 2026-01-23 | |
| 2024-03-31 | $1,222,943 | 42,040 | Shares | Sole | 2024-05-22 | |
| No filing history on record for this holder in this stock. | ||||||